Here below are the publications (5) participated by Federica Sallusto along with David Jarrossay (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch
3) ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Federica Sallusto
is currently collaborating with
Istituto di Ricerca in Biomedicina (IRB) (Rif. IRB)
Via Francesco Chiesa 5
6500 Bellinzona
is currently collaborating with
Istituto di Ricerca in Biomedicina (IRB) (Rif. IRB)
Via Francesco Chiesa 5
6500 Bellinzona
Federica Sallusto
on behalf of
Istituto di Ricerca in Biomedicina (IRB) USI (Rif. IRB)
is currently participating in the Research Group
Immunologia Cellulare
as Group Leader [Rif. 55110]
on behalf of
Istituto di Ricerca in Biomedicina (IRB) USI (Rif. IRB)
is currently participating in the Research Group
Immunologia Cellulare
as Group Leader [Rif. 55110]